Personalized drug trials aim to end medication guesswork for seniors with heart failure
NCT ID NCT05585125
First seen Nov 01, 2025 · Last updated Jun 10, 2026 · Updated 30 times
Summary
This study tests whether a personalized approach called N-of-1 trials can help older adults (65+) with a type of heart failure (HFpEF) feel more confident about continuing or stopping their beta-blocker medication. Twenty participants will go through a tailored trial to see how the drug affects them personally. The goal is to improve decision-making and reduce uncertainty about medication use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Weill Cornell Medicine
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.